Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
OPCH 
Option Care Health Inc (OPCH)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
10/31/2025: OPCH (2-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Number of Analysts
10 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $35.5
1 Year Target Price $35.5
| 6 | Strong Buy |
| 3 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -1.13% | Avg. Invested days 52 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/31/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 4.13B USD | Price to earnings Ratio 20.66 | 1Y Target Price 35.5 |
Price to earnings Ratio 20.66 | 1Y Target Price 35.5 | ||
Volume (30-day avg) 10 | Beta 0.89 | 52 Weeks Range 21.39 - 35.53 | Updated Date 11/3/2025 |
52 Weeks Range 21.39 - 35.53 | Updated Date 11/3/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 1.26 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date 2025-10-30 | When - | Estimate 0.4267 | Actual 0.45 |
Profitability
Profit Margin 3.78% | Operating Margin (TTM) 5.89% |
Management Effectiveness
Return on Assets (TTM) 6.03% | Return on Equity (TTM) 15.03% |
Valuation
Trailing PE 20.66 | Forward PE 16.05 | Enterprise Value 5548177442 | Price to Sales(TTM) 0.75 |
Enterprise Value 5548177442 | Price to Sales(TTM) 0.75 | ||
Enterprise Value to Revenue 1.03 | Enterprise Value to EBITDA 13.73 | Shares Outstanding 158732706 | Shares Floating 149499224 |
Shares Outstanding 158732706 | Shares Floating 149499224 | ||
Percent Insiders 0.78 | Percent Institutions 104.49 |
Upturn AI SWOT
Option Care Health Inc
Company Overview
History and Background
Option Care Health, Inc. was formed in 2015 from the combination of Walgreens Infusion Services and Option Care Enterprises, Inc. Its roots extend further back, with predecessors providing home and alternate site infusion services for several decades. The company has grown organically and through acquisitions to become a leading independent provider of home and alternate site infusion services.
Core Business Areas
- Infusion Services: Provides a range of therapies for acute and chronic conditions, including anti-infectives, nutrition support, and immunoglobulin therapy, delivered in patients' homes and alternative infusion sites. Clinical pharmacists, nurses, and other professionals are key for therapy management and patient safety.
Leadership and Structure
The company is led by a CEO and a senior management team overseeing various functional areas, including operations, finance, and clinical services. The organizational structure supports a decentralized approach to deliver personalized care in local markets.
Top Products and Market Share
Key Offerings
- Anti-Infective Therapy: Administration of intravenous antibiotics and antifungals to treat infections at home. Competitors include CVS Health (CVS) (through Coram) and other regional/local infusion providers. Market share information is difficult to find and constantly changes. This is a highly competitive market that changes regularly
- Nutrition Support: Providing specialized nutrition, including parenteral (IV) and enteral (tube feeding) nutrition, to patients who cannot obtain sufficient nutrition through oral intake. Competitors include CVS Health (CVS) (through Coram) and other regional/local infusion providers. Market share information is difficult to find and constantly changes. This is a highly competitive market that changes regularly
- Immunoglobulin Therapy: Infusion of immunoglobulin (IG) to treat immune deficiencies and autoimmune diseases. Competitors include CVS Health (CVS) (through Coram) and other regional/local infusion providers. Market share information is difficult to find and constantly changes. This is a highly competitive market that changes regularly
Market Dynamics
Industry Overview
The home and alternate site infusion market is growing, driven by factors such as an aging population, increasing prevalence of chronic diseases, rising healthcare costs, and patient preference for home-based care.
Positioning
Option Care Health is a leading independent provider of infusion services, known for its clinical expertise, national footprint, and focus on patient outcomes. Competitive advantages include its ability to provide complex therapies and its strong relationships with payers and prescribers.
Total Addressable Market (TAM)
The TAM is estimated to be in the tens of billions of dollars annually. Option Care Health is well-positioned to capture a significant share of the market due to its scale, expertise, and focus on complex therapies.
Upturn SWOT Analysis
Strengths
- National Footprint
- Clinical Expertise
- Strong Relationships with Payers and Prescribers
- Focus on Complex Therapies
- Accreditations and Certifications
Weaknesses
- Reliance on Reimbursement Rates
- Competition from Larger Healthcare Providers
- Regulatory Risks
- Need for Continuous Improvement in Operational Efficiency
Opportunities
- Expansion into New Therapies
- Acquisitions of Smaller Infusion Providers
- Development of Value-Based Care Programs
- Leveraging Technology to Improve Patient Outcomes
- Growth in the Alternate Site Infusion Market
Threats
- Changes in Reimbursement Policies
- Increased Competition
- Cybersecurity Risks
- Drug Shortages
- Economic Downturn
Competitors and Market Share
Key Competitors
- CVS (CVS)
- BioScrip
- Diplomat Pharmacy (now part of OptumRx)
Competitive Landscape
Option Care Health is a leading independent provider with a strong focus on clinical expertise. Its competitors include large healthcare providers and regional players. Option Care Health's advantages include its national footprint and ability to provide complex therapies. Disadvantages include competition from larger, more diversified healthcare companies.
Major Acquisitions
BioScrip
- Year: 2019
- Acquisition Price (USD millions): 240
- Strategic Rationale: Expanded Option Care Health's geographic footprint and strengthened its position as a leading independent provider of infusion services.
Growth Trajectory and Initiatives
Historical Growth: Option Care Health has grown significantly through organic expansion and acquisitions.
Future Projections: Provide projections for Option Care Health Inc's future growth based on analyst estimates.
Recent Initiatives: Highlight recent strategic initiatives undertaken by Option Care Health Inc.
Summary
Option Care Health is a key player in the home infusion space, benefiting from a growing market driven by an aging population and a shift towards home-based care. Their competitive advantage lies in clinical expertise and national reach. However, they face ongoing pressure from reimbursement changes and larger healthcare companies. To maintain their position, they need to continue focusing on operational efficiency, technological advancements, and value-based care models. Option Care health has seen stable growth through the years, but is only a small part of the market so they need to stay efficient to compete against local and regional players and also CVS.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company reports
- Analyst reports
- Industry publications
Disclaimers:
This analysis is for informational purposes only and does not constitute financial advice. Market share data is based on estimates and may vary. Future performance is not guaranteed.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Option Care Health Inc
Exchange NASDAQ | Headquaters Bannockburn, IL, United States | ||
IPO Launch date 1996-08-15 | CEO, President & Director Mr. John C. Rademacher | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 8000 | Website https://www.optioncarehealth.com |
Full time employees 8000 | Website https://www.optioncarehealth.com | ||
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as Duchenne muscular dystrophy, multiple sclerosis, Alzheimer's disease, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.